XML 61 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]    
Fair value of convertible loans beginning balance $ 7,140 $ 7,148
Interest recognized in interest income, net 238 217
Foreign currency remeasurement recognized in other expense, net 195 (257)
Unrealized gain (loss) recognized in other comprehensive loss 117 (615)
Conversion of Second Convertible Loan into preferred equity securities   (671)
Fair value of convertible loans ending balance 7,690 5,820
Amortized cost basis of Neo Medical Convertible Loans at June 30 $ 6,340 $ 5,496